Adopting a Practical Statistical Approach for Evaluating Assay Agreement in Drug Discovery
Open Access
- 1 August 2005
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 10 (5) , 508-516
- https://doi.org/10.1177/1087057105275725
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Data Concordance from a Comparison between Filter Binding and Fluorescence Polarization Assay Formats for Identification of ROCK-II InhibitorsSLAS Discovery, 2003
- Comparison of Assay Technologies for a Nuclear Receptor Assay Screen Reveals Differences in the Sets of Identified Functional AntagonistsSLAS Discovery, 2003
- Comparison of Assay Technologies for a Tyrosine Kinase Assay Generates Different Results in High Throughput ScreeningSLAS Discovery, 2002
- Development of a Homogeneous Time-Resolved Fluorescence Assay for High Throughput Screening to Identify Lck Inhibitors: Comparison with Scintillation Proximity Assay and Streptavidin-Coated Plate AssaySLAS Discovery, 2000
- Microchip-based systems for target validation and HTSDrug Discovery Today, 2000
- Microchip-based systems for target validation and HTSDrug Discovery Today, 2000
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Scintillation proximity assayNature, 1989
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973